curacle co.,ltd. (KOSDAQ:365270)
17,550
-220 (-1.24%)
At close: Apr 28, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 373.89 billion as of April 28, 2026. Its market cap has increased by 287.91% in one year.
Market Cap
373.89B
Enterprise Value
363.21B
Revenue
7.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
17,550.00
Market Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 373.89B, a decrease of -8.67%. That is a compound annual growth rate of -1.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 373.89B | 149.60% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 385.15B |
| Y-Biologics | 351.37B |
| TiumBio | 348.94B |
| S.Biomedics | 426.67B |
| HansBiomed | 443.53B |
| NIBEC | 309.20B |
| Bio Solution | 295.98B |
| Kanaph Therapeutics | 497.53B |